The effect of Galleria mellonella hemolymph polypeptides on Legionella gormanii

Elżbieta Chmiel1, Marta Palusinska-Szysz1, Agnieszka Zdybicka-Barabas2

  • 1Department of Genetics and Microbiology, Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University, Lublin, Poland.

Insights

Galleria mellonella hemolymph extract and apolipophorin III show potent activity against Legionella gormanii, a cause of pneumonia. These insect defense compounds offer potential for developing new anti-Legionella drugs.

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Legionella gormanii is a significant cause of community-acquired pneumonia.
  • Understanding novel antimicrobial agents against Legionella is crucial for public health.

Purpose of the Study:

  • To investigate the anti-Legionella gormanii activity of Galleria mellonella hemolymph extract and apolipophorin III (apoLp-III).
  • To analyze the effects of apoLp-III on Legionella gormanii cell surface morphology.

Main Methods:

  • In vitro assessment of bacterial survival rates after exposure to hemolymph extract and apoLp-III.
  • Atomic force microscopy (AFM) to visualize changes in bacterial cell surface structure.

Main Results:

  • Galleria mellonella hemolymph extract reduced L. gormanii survival by 75% at 0.025 mg/ml.
  • Apolipophorin III decreased bacterial survival by 10% at the same concentration.
  • AFM revealed apoLp-III-induced alterations in the bacterial cell surface.

Conclusions:

  • Insect defense polypeptides, like apoLp-III, exhibit significant anti-Legionella effects.
  • These findings suggest potential for developing novel antimicrobial therapies targeting Legionella infections.

Related Concept Videos